South Sudan COVAX vaccine roll-out news


 

24 March 2021

PRESS RELEASE

South Sudan receives first batch of COVID-19 vaccines through the COVAX Facility

“Today is a historic day for South Sudan and its fight against COVID-19,” said Patience Musanhu, Gavi Senior Country Manager for South Sudan. “This delivery is the product of an unprecedented global partnership to ensure every country has access to COVID-19 vaccines. These vaccines are safe, they are effective, and they will be an important tool in the fight against this disease.”

Read more


*SII-AstraZeneca (COVISHIELD) vaccine, licensed and manufactured by Serum Institute of India

Subscribe to our newsletter